Design of a prospective patient‐level pooled analysis of two parallel trials of empagliflozin in patients with established heart failure

AIM: The EMPEROR‐Reduced trial demonstrated that empagliflozin reduced the combined risk of cardiovascular death or hospitalization for heart failure in patients with a reduced ejection fraction, and the EMPEROR‐Preserved trial is currently evaluating the effect of the drug on the same endpoint in p...

詳細記述

保存先:
書誌詳細
出版年:Eur J Heart Fail
主要な著者: Packer, Milton, Butler, Javed, Filippatos, Gerasimos, Zannad, Faiez, Ferreira, Joao Pedro, Zeller, Cordula, Brueckmann, Martina, Jamal, Waheed, Pocock, Stuart J., Anker, Stefan D.
フォーマット: Artigo
言語:Inglês
出版事項: John Wiley & Sons, Ltd. 2020
主題:
Study Design
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7898542/
https://ncbi.nlm.nih.gov/pubmed/33251659
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ejhf.2065
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料